This inventor holds 1 USPTO granted patent. Top assignee: Gesellschaft Fur Biotechnologische Forschung Mbh (Gbf). Active years: 1991.
Company Filing History:
Years Active: 1991
Title: Andreas Meyerhans: Innovator in Oligonucleotide Purification
Introduction
Andreas Meyerhans is a notable inventor based in Pinneberg, Germany. He has made significant contributions to the field of biotechnology, particularly in the purification of synthetic oligonucleotides. His innovative approach has streamlined processes that were previously time-consuming and complex.
Latest Patents
Meyerhans holds a patent for an "Improved process for the purification of synthetic oligonucleotides." This patent describes a method that drastically simplifies the purification process. The process involves adsorbing the deprotection solution on a carrier with reversed phase and optional ion exchanger properties. It allows for the removal of oligonucleotides without lipophilic protecting groups, followed by the cleavage of their protecting groups. The oligonucleotides are then washed, eluted from the carrier, and purified using established methods. This innovation has the potential to enhance efficiency in oligonucleotide research and applications.
Career Highlights
Meyerhans is associated with Gesellschaft für Biotechnologische Forschung mbH (GBF), where he has been instrumental in advancing biotechnological research. His work has not only contributed to his field but has also positioned him as a key figure in the biotechnology community.
Collaborations
Meyerhans has collaborated with notable colleagues, including Helmut Blocker and Ronald Frank. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Andreas Meyerhans is a distinguished inventor whose work in the purification of synthetic oligonucleotides has made a significant impact in biotechnology. His innovative processes continue to influence the field and enhance research capabilities.